Edgestream Partners L.P. bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,745 shares of the financial services provider’s stock, valued at approximately $344,000.
A number of other institutional investors and hedge funds also recently modified their holdings of CME. Fiduciary Trust Co. purchased a new stake in CME Group in the second quarter worth about $105,000. Parallel Advisors LLC lifted its holdings in CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. Whittier Trust Co. increased its stake in shares of CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 27 shares in the last quarter. RidgeWorth Capital Management LLC increased its stake in shares of CME Group by 55.5% during the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $135,000 after purchasing an additional 406 shares in the last quarter. Finally, Guardian Life Insurance Co. of America increased its stake in shares of CME Group by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock valued at $156,000 after purchasing an additional 9 shares in the last quarter. Institutional investors and hedge funds own 82.64% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was originally reported by BBNS and is the sole property of of BBNS. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://baseballnewssource.com/markets/edgestream-partners-l-p-invests-344000-in-cme-group-inc-cme-stock/1605208.html.
In other CME Group news, Director Dennis Suskind sold 750 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $129.34, for a total transaction of $97,005.00. Following the completion of the sale, the director now directly owns 5,059 shares of the company’s stock, valued at approximately $654,331.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $124.50, for a total value of $311,250.00. Following the sale, the chief financial officer now directly owns 38,495 shares of the company’s stock, valued at $4,792,627.50. The disclosure for this sale can be found here. Insiders sold a total of 48,244 shares of company stock valued at $6,021,890 over the last ninety days. 0.57% of the stock is currently owned by corporate insiders.
Shares of CME Group Inc. (CME) opened at 134.17 on Friday. The company has a market cap of $45.61 billion, a P/E ratio of 27.39 and a beta of 0.72. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $134.36. The firm has a 50-day moving average of $126.73 and a 200-day moving average of $122.14.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The company had revenue of $925.00 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm’s revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.14 EPS. Equities research analysts forecast that CME Group Inc. will post $4.82 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.
A number of equities analysts have weighed in on CME shares. Royal Bank Of Canada set a $130.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Monday, June 12th. UBS AG reaffirmed a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. Citigroup Inc. started coverage on shares of CME Group in a research note on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price for the company. Jefferies Group LLC reissued a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. Finally, Deutsche Bank AG reduced their price target on shares of CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research report on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $133.22.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with our FREE daily email newsletter.